Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Spahn

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Deutsches Arzteblatt International|January 20, 2011
Deficits in the management of patients with adrenocortical carcinoma in GermanySarah Johanssen, Stefanie Hahner, Wolfgang Saeger, et al.
Scientific Reports|June 11, 2026
Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patientsRenata Dubrovska, Markus Eckstein, Rudolf Jung, et al.
Praxis|September 20, 2018
[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]Aurelius Omlin, Martin Spahn, Jörg Beyer, et al.
Frontiers in Cell and Developmental Biology|December 21, 2017
ALK1Fc Suppresses the Human Prostate Cancer Growth in <i>in Vitro</i> and <i>in Vivo</i> Preclinical ModelsLetizia Astrologo, Eugenio Zoni, Sofia Karkampouna, et al.
Urologic Oncology|December 27, 2015
Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancerPaolo Dell'Oglio, Robert Jeffrey Karnes, Steven Joniau, et al.
Swiss Medical Weekly|September 8, 2021
Swiss germ-cell cancer consensus recommendationsJörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
European Urology|December 14, 2011
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancerAlberto Briganti, Steven Joniau, Paolo Gontero, et al.
European Urology|September 11, 2012
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysisAlberto Briganti, Martin Spahn, Steven Joniau, et al.
European Urology|February 4, 2014
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studySteven Joniau, Alberto Briganti, Paolo Gontero, et al.
Urologic Oncology|February 11, 2015
Natural history of surgically treated high-risk prostate cancerAlberto Briganti, Robert Jeffrey Karnes, Giorgio Gandaglia, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Deutsches Arzteblatt International|January 20, 2011
Deficits in the management of patients with adrenocortical carcinoma in GermanySarah Johanssen, Stefanie Hahner, Wolfgang Saeger, et al.
Scientific Reports|June 11, 2026
Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patientsRenata Dubrovska, Markus Eckstein, Rudolf Jung, et al.
Praxis|September 20, 2018
[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]Aurelius Omlin, Martin Spahn, Jörg Beyer, et al.
Frontiers in Cell and Developmental Biology|December 21, 2017
ALK1Fc Suppresses the Human Prostate Cancer Growth in <i>in Vitro</i> and <i>in Vivo</i> Preclinical ModelsLetizia Astrologo, Eugenio Zoni, Sofia Karkampouna, et al.
Urologic Oncology|December 27, 2015
Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancerPaolo Dell'Oglio, Robert Jeffrey Karnes, Steven Joniau, et al.
Swiss Medical Weekly|September 8, 2021
Swiss germ-cell cancer consensus recommendationsJörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
European Urology|December 14, 2011
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancerAlberto Briganti, Steven Joniau, Paolo Gontero, et al.
European Urology|September 11, 2012
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysisAlberto Briganti, Martin Spahn, Steven Joniau, et al.
European Urology|February 4, 2014
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studySteven Joniau, Alberto Briganti, Paolo Gontero, et al.
Urologic Oncology|February 11, 2015
Natural history of surgically treated high-risk prostate cancerAlberto Briganti, Robert Jeffrey Karnes, Giorgio Gandaglia, et al.
Pageof 11